Health
New study helps understand molecular profile of tumors in cancer patients – News-Medical.Net
Researchers from the University Hospitals in Zurich and Basel, ETH Zurich, University of Zurich and the pharmaceutical company Roche have set out to improve cancer…
Researchers from the University Hospitals in Zurich and Basel, ETH Zurich, University of Zurich and the pharmaceutical company Roche have set out to improve cancer diagnostics by developing a platform of state-of-the-art molecular biology methods.
The “Tumor Profiler” project aims to derive the comprehensive molecular profile of tumors in cancer patients, which has the potential to predict the efficacy of a host of new cancer medications. It will therefore make it possible to offer treating physicians…
-
Noosa News18 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General19 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General16 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
General24 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says